Navigation Links
Easily Lift, Transfer and Reposition Patients with Ground-Breaking Liftaem(TM) System from Smart Medical Technology, Inc.
Date:11/12/2007

DARIEN, Ill., Nov. 12 /PRNewswire/ -- The Liftaem(TM) safe-patient- handling system enables healthcare professionals to easily transfer a patient from a bed to a stretcher or other surface on a single-patient-use inflatable mat -- even when the patient weighs up to 1,000 lbs. It's the only product of its kind featuring single-patient-use mats to prevent cross-contamination -- a priority in health care.

"Our vision is to develop culture-changing innovations to better manage and monitor healthcare environments," states Smart Medical Technology Chairman and CEO James Patrick. "We believe therapy and safety should always share the same platform."

The inflatable mats are placed on the patients' beds when they are admitted and remain with them for the duration of their stay. Carts used for inflation are placed throughout the hospital in areas with high numbers of patient transfers.

Smart Medical Technology developed the Liftaem(TM) to address the serious problems associated with manually lifting, transferring and repositioning patients, including:

-- Nurses lose a combined average of 750,000 work days each year as a

result of back injury, according to the U.S. Bureau of Labor

Statistics.

-- Patients may suffer pain, skin tears, abrasions, dislocations, tube

dislodgement or even be dropped.

Liftaem(TM) has applications in areas such as bariatrics, maternity wards, operating rooms, intensive care and long-term care facilities.

For additional information on the Liftaem(TM) safe-patient-handling system, contact James Patrick at 630.964.1689 or visit http://www.smartmedtechnology.com.

Smart Medical Technology, Inc. is a creative design and manufacturing company that develops solutions for the healthcare industry to improve patient care and reduce expenses -- http://www.smartmedt
'/>"/>

SOURCE Smart Medical Technology, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. XTL Receives Staff Letter From NASDAQ; XTL may Transfer its ADR Listing to the NASDAQ Capital Market
2. ThromboGenics Announces Successful Completion of Technology Transfer to Bharat Biotech for Production of Novel Thrombolytic Agent
3. XTL to Appeal NASDAQ Staff Determination; XTL May Transfer its ADR Listing to the NASDAQ Capital Market
4. InVitrias Animal Free Lacromin(TM) Provides a Cost-Effective Improvement Over Transferrin
5. Smart Medical Technology, Inc. Awarded Novation Contract for Ground-breaking Liftaem(TM) System that Aids Lifting and Transferring Patients
6. Human Pheromone Sciences Enters Into Agreement to Reposition and Promote its Natural Attraction(R) Brand
7. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
8. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
9. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
10. PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials
11. Baxter to Launch GARDian(TM), a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/7/2008)...ected to aid drug discovery by allowing for the ra...gle reaction, ST. LOUIS, Oct. 7 /PRNewswire-First...o announce that it has signed an exclusive licensi...bana-Champaign allowing,Sigma-Aldrich to offer res...ogates for use in Suzuki-Miyaura coupling to resea...
(Date:10/7/2008)...s to focus on new patient data supporting the Ross...ynerGraft processed human heart .../- CryoLife, Inc. (NYSE: C...ocessing company, announced today,that cardiovascu...e in the,Ross Summit 2008, a two-day surgical cong...
(Date:10/7/2008)...Institutes of Health, The Infectious Disease Resea...Launch and Board of Advisors, SEATTLE, Oct. 7 /PR...,Initiative today announced its first acquisition ...osis (TB) drug candidates. Agreements were reached...nd the Microbial Chemistry,Research Foundation (MC...
(Date:10/7/2008)... Oct. 7 /- BioEnergy International, L...r and manufacturer of,next-generation, renewable b...f Norman R. Augustine to its Board of Advisors eff...f distinguished leadership and innovation,at the h...g in his role as,Chairman and Chief Executive Offi...
Breaking Biology Technology:Sigma-Aldrich and the University of Illinois Offer New Boronic Acid Surrogates to Researchers Worldwide Through Licensing Agreement 2Sigma-Aldrich and the University of Illinois Offer New Boronic Acid Surrogates to Researchers Worldwide Through Licensing Agreement 3CryoLife Hosts Worldwide Surgical Congress for the Ross Procedure 2CryoLife Hosts Worldwide Surgical Congress for the Ross Procedure 3CryoLife Hosts Worldwide Surgical Congress for the Ross Procedure 4Update: The Lilly TB Drug Discovery Initiative Begins Work on New Compounds to Fill Early-Stage TB Drug Pipeline 2Update: The Lilly TB Drug Discovery Initiative Begins Work on New Compounds to Fill Early-Stage TB Drug Pipeline 3Update: The Lilly TB Drug Discovery Initiative Begins Work on New Compounds to Fill Early-Stage TB Drug Pipeline 4Update: The Lilly TB Drug Discovery Initiative Begins Work on New Compounds to Fill Early-Stage TB Drug Pipeline 5BioEnergy International, LLC Announces Norman R. Augustine to Join Advisory Board 2BioEnergy International, LLC Announces Norman R. Augustine to Join Advisory Board 3
...eenah, Wis. - Thanks to a classified contract fro...alization company headquartered here, reported rec...rter ended July 1, 2006, despite the closing of it...y,s financial picture is tempered, however, by for...th quarter, which caused its stock price to fall b...
...ditor,s note: This article first appeared in Gene...ere is good news for inventors. Using an invention...ger than a year, will not by itself cause a court ...invention. , ,This rule was pronounced in response...nt asserted that the patent was invalid due to pri...
...auwatosa, Wis. - Personalized medicine is a conce...but people in the know believe so-called genetic-b...ic-based medicine, personal genetic profiles will ...o various diseases, and to develop disease managem...vironmental characteristics. , , Stephens Crack...
... shkosh, Wis. - BidRx , a new online company th...iption medications, is attempting to create a new ... has gone live with its new web site, where consum...are costs and obtain other information about presc...e for their medications out of pocket, the site,s ...
Other Biology Technology:Defense contract helps Plexus gain record profits 2With patents and research tools, when is private really public? 2With patents and research tools, when is private really public? 3With patents and research tools, when is private really public? 4With patents and research tools, when is private really public? 5Medical College researcher working to make genetic-based medicine a reality 2Medical College researcher working to make genetic-based medicine a reality 3Will BidRx start a drug price war? 2Will BidRx start a drug price war? 3Will BidRx start a drug price war? 4
(Date:10/7/2008)...nsional. That,s true even in the laboratory, where...evelop and what happens when their growth is abnor...o develop three-dimensional cell culture systems t...ugs in a system that more closely mimics the way i...is the cost of commercial media for growing such c...
(Date:10/7/2008)... Li Lab has characterized a mechanism that allows ...ocytes. By tracking chromosome movement in live mo...can recruit to their vicinity a protein called for...e majority of the cytoplasm a requirement for emb...other daughter cell (called a polar body) resultin...
(Date:10/7/2008)... 2008 Burnham Institute for Medical Research toda... that binds to Bcl-2, a protein that protects canc...it into a cancer cell killer. The research, which ...er 7 edition of Cancer Cell , may lead to new can...n implicated in protecting cancer cells from apopt...
(Date:10/6/2008)...mption of red wine may decrease the risk of lung c... issue of Cancer Epidemiology, Biomarkers & Preve...ancer Research. , "An antioxidant component in ...larly among smokers," said Chun Chao, Ph.D., a res...of Research and Evaluation in Pasadena, California...
Breaking Biology News(10 mins):Egg whites solve the 3-D problem 2Red wine may lower lung cancer risk 2ULURU Inc Announces the Launch Plan for Altrazeal 28TM 29 18793 1ULURU Inc Announces the Launch Plan for Altrazeal 28TM 29 18793 2ULURU Inc Announces the Launch Plan for Altrazeal 28TM 29 18793 3Susan G Komen for the Cures 28R 29 Moddelmog Calls for Congress to Launch Colossal Cancer Crusade 18788 1Susan G Komen for the Cures 28R 29 Moddelmog Calls for Congress to Launch Colossal Cancer Crusade 18788 2Susan G Komen for the Cures 28R 29 Moddelmog Calls for Congress to Launch Colossal Cancer Crusade 18788 3Alpharma Presents Data Addressing Abuse Liability Features Safety and Efficacy on ALO 01 28EMBEDA 28TM 29 29 28morphine sulfate extended release wi 2014 1Alpharma Presents Data Addressing Abuse Liability Features Safety and Efficacy on ALO 01 28EMBEDA 28TM 29 29 28morphine sulfate extended release wi 2014 2Alpharma Presents Data Addressing Abuse Liability Features Safety and Efficacy on ALO 01 28EMBEDA 28TM 29 29 28morphine sulfate extended release wi 2014 3Alpharma Presents Data Addressing Abuse Liability Features Safety and Efficacy on ALO 01 28EMBEDA 28TM 29 29 28morphine sulfate extended release wi 2014 4Alpharma Presents Data Addressing Abuse Liability Features Safety and Efficacy on ALO 01 28EMBEDA 28TM 29 29 28morphine sulfate extended release wi 2014 5Alpharma Presents Data Addressing Abuse Liability Features Safety and Efficacy on ALO 01 28EMBEDA 28TM 29 29 28morphine sulfate extended release wi 2014 6Alpharma Presents Data Addressing Abuse Liability Features Safety and Efficacy on ALO 01 28EMBEDA 28TM 29 29 28morphine sulfate extended release wi 2014 7Scientists identify key roadblock to gene expression 18781 1Scientists identify key roadblock to gene expression 18781 2
...itive tissue throughout the body have an undesirab...ions away. To overcome this hurdle, Johns Hopkins ... with a chemical that helps them slip through this...e coated particles, the researchers also discovere...eviously thought, providing a doorway that should ...
... able to eat prawns without the fear of an adverse...ng step towards removing from prawns the proteins ...to genetic manipulation, reports Lisa Richards in ... , Li Zhenxing led the research at the Ocean Unive...awns with a combination of heat and irradiation si...
...ty School of Medicine has helped confirm the reli...shering in the long-promised era of personalized .... , The Stanford group was one of the five sites t...entify patients who are at high risk of developin...at means high-risk patients could be directed tow...
...ill reveal in the 29 March 2007 issue of the journ...of important structures that control how genes are...e. "For the first time, we are seeing in very hig...s control the expression of an organism,s genes," ...nd molecular biology and the study,s lead investig...
Other Biology News:Coated nanoparticles solve sticky drug-delivery problem 2Coated nanoparticles solve sticky drug-delivery problem 3New test helps identify hepatitis C patients at high risk of developing cirrhosis 2New test helps identify hepatitis C patients at high risk of developing cirrhosis 3Scientists reveal structure of gateways to gene control 2Scientists reveal structure of gateways to gene control 3Scientists reveal structure of gateways to gene control 4
MagSi uniform silica particles coated with a carboxyl group containing polymer, covalently attached to the bead surface.
Antibeta-lactoglobulin monoclonal antibody(CD-2)
MAb to Vasopressin Preservative: NaN3
...α, clone 8G8/5 GenBank Accession Number : N...lpha/gamma fusion protein corresponding to residue...0 of human AP-2γ Formulation: 0.1M Tris-glyc... the addition of glycerol to 30% Quality Assurance...
Biology Products: